Search research articles
Contact Us
Filters
Showing results (61-70 of 155) with videos related to
Page
of 16
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 4, 2005
YKL-40 expression is associated with poorer response to radiation and shorter overall survival in glioblastoma
Christopher E Pelloski, Anita Mahajan, Moshe Maor, et al.
Neurosurgery
|
October 26, 2012
ELTD1, a potential new biomarker for gliomas
Rheal A Towner, Randy L Jensen, Howard Colman, et al.
Cancer Medicine
|
October 24, 2024
The association of diabetes mellitus and routinely collected patient-reported outcomes in patients with cancer. A real-world cohort study
Dominik J Ose, Emmanuel Adediran, Bayarmaa Mark, et al.
Cancer
|
May 2, 2013
Phase 1/1b study of lonafarnib and temozolomide in patients with recurrent or temozolomide refractory glioblastoma
Shlomit Yust-Katz, Diane Liu, Ying Yuan, et al.
Molecular Cancer Therapeutics
|
January 8, 2010
Glioblastoma cancer-initiating cells inhibit T-cell proliferation and effector responses by the signal transducers and activators of transcription 3 pathway
Jun Wei, Jason Barr, Ling-Yuan Kong, et al.
Acta Neuropathologica
|
September 28, 2018
cIMPACT-NOW update 3: recommended diagnostic criteria for "Diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV"
Daniel J Brat, Kenneth Aldape, Howard Colman, et al.
Cancer Research
|
March 9, 2005
Integrated array-comparative genomic hybridization and expression array profiles identify clinically relevant molecular subtypes of glioblastoma
Janice M Nigro, Anjan Misra, Li Zhang, et al.
Biorxiv : the Preprint Server for Biology
|
April 3, 2026
Comprehensive analysis of TEAD inhibition in meningioma identifies MEK and mTOR inhibition as effective combination therapies against resistant lines
Dylan J Keiser, Meghan S Buddy, Solmaz Mojarad-Jabali, et al.
Cell Reports. Medicine
|
February 8, 2025
Combined inhibition of focal adhesion kinase and RAF/MEK elicits synergistic inhibition of melanoma growth and reduces metastases
Jared Almazan, Tursun Turapov, David A Kircher, et al.
Stem Cells (Dayton, Ohio)
|
September 17, 2013
A high Notch pathway activation predicts response to γ secretase inhibitors in proneural subtype of glioma tumor-initiating cells
Norihiko Saito, Jun Fu, Siyuan Zheng, et al.
Page
of 16
Search research articles
Search
Showing results (61-70 of 155) with videos related to
Sort By:
Page
of 16
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 4, 2005
YKL-40 expression is associated with poorer response to radiation and shorter overall survival in glioblastoma
Christopher E Pelloski, Anita Mahajan, Moshe Maor, et al.
Neurosurgery
|
October 26, 2012
ELTD1, a potential new biomarker for gliomas
Rheal A Towner, Randy L Jensen, Howard Colman, et al.
Cancer Medicine
|
October 24, 2024
The association of diabetes mellitus and routinely collected patient-reported outcomes in patients with cancer. A real-world cohort study
Dominik J Ose, Emmanuel Adediran, Bayarmaa Mark, et al.
Cancer
|
May 2, 2013
Phase 1/1b study of lonafarnib and temozolomide in patients with recurrent or temozolomide refractory glioblastoma
Shlomit Yust-Katz, Diane Liu, Ying Yuan, et al.
Molecular Cancer Therapeutics
|
January 8, 2010
Glioblastoma cancer-initiating cells inhibit T-cell proliferation and effector responses by the signal transducers and activators of transcription 3 pathway
Jun Wei, Jason Barr, Ling-Yuan Kong, et al.
Acta Neuropathologica
|
September 28, 2018
cIMPACT-NOW update 3: recommended diagnostic criteria for "Diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV"
Daniel J Brat, Kenneth Aldape, Howard Colman, et al.
Cancer Research
|
March 9, 2005
Integrated array-comparative genomic hybridization and expression array profiles identify clinically relevant molecular subtypes of glioblastoma
Janice M Nigro, Anjan Misra, Li Zhang, et al.
Biorxiv : the Preprint Server for Biology
|
April 3, 2026
Comprehensive analysis of TEAD inhibition in meningioma identifies MEK and mTOR inhibition as effective combination therapies against resistant lines
Dylan J Keiser, Meghan S Buddy, Solmaz Mojarad-Jabali, et al.
Cell Reports. Medicine
|
February 8, 2025
Combined inhibition of focal adhesion kinase and RAF/MEK elicits synergistic inhibition of melanoma growth and reduces metastases
Jared Almazan, Tursun Turapov, David A Kircher, et al.
Stem Cells (Dayton, Ohio)
|
September 17, 2013
A high Notch pathway activation predicts response to γ secretase inhibitors in proneural subtype of glioma tumor-initiating cells
Norihiko Saito, Jun Fu, Siyuan Zheng, et al.
Page
of 16